Word

KERNAL

Status

Pending

Status Code

645

Status Date

Monday, December 4, 2023

Serial Number

97507484

Mark Type

4000

Filing Date

Monday, July 18, 2022

Trademark Owner History

Kernal Biologics

Classifications

5 Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes

1 Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences for scientific purposes; polypeptide encoding nucleic acids for laboratory use

42 Medical and scientific research services in the fields of nucleic acid sciences for medical, scientific and technological applications; design, engineering, research, development, consultation and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; design, engineering, research, development, consultation and testing services in the field of mRNA sciences for medical, scientific and technological applications; research and development services of new medical, technological and scientific products, treatments and techniques for others in the fields of mRNA; consultation services in the pharmaceutical and biotechnology fields related to mRNA research, mRNA engineering, mRNA pharmaceutical development

Trademark Events

Dec 4, 2023

Notification Of Final Refusal Emailed

Dec 4, 2023

Final Refusal E-Mailed

Dec 4, 2023

Final Refusal Written

Oct 30, 2023

Teas/Email Correspondence Entered

Oct 30, 2023

Correspondence Received In Law Office

Oct 30, 2023

Teas Response To Office Action Received

Oct 18, 2023

Teas Change Of Correspondence Received

Oct 18, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 18, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Oct 18, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 18, 2023

Teas Change Of Owner Address Received

Jul 21, 2023

Application Extension Granted/Receipt Provided

Jul 21, 2023

Application Extension To Response Period - Received

May 3, 2023

Notification Of Non-Final Action E-Mailed

May 3, 2023

Non-Final Action E-Mailed

May 3, 2023

Non-Final Action Written

May 3, 2023

Assigned To Examiner

Aug 8, 2022

New Application Office Supplied Data Entered

Jul 21, 2022

New Application Entered